Koers Stemcell Holdings, Inc. Other OTC
Aandelen
STMM
US85858N2027
Farmaceutische producten
Omzet 2016 | 3,34 mln. 3,12 mln. | Omzet 2017 | 6,18 mln. 5,77 mln. | Marktkapitalisatie | 1,64 mln. 1,53 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | 1 mln. 934K | Nettowinst (verlies) 2017 | 2 mln. 1,87 mln. | EV/omzet 2016 * | - |
Nettoliquiditeiten 2016 * | - 0 | Nettoliquiditeiten 2017 * | - 0 | EV/omzet 2017 * | - |
K/w-verhouding 2016 * |
-
| K/w-verhouding 2017 * |
-
| Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 * |
-
| Vrij verhandelbaar | 99% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,33% | 94,45 mld. | |
-1,71% | 38,9 mld. | |
-12,83% | 32,56 mld. | |
-12,14% | 15,98 mld. | |
-0,68% | 13,82 mld. | |
-12,63% | 11,34 mld. | |
+163,45% | 9,81 mld. | |
-53,23% | 9,67 mld. | |
+3,52% | 8,91 mld. |